About
Contact & Profiles
A5077183914
Research Areas
- Cancer, Stress, Anesthesia, and Immune Response
- Fibroblast Growth Factor Research
- Chemokine receptors and signaling
- Cancer, Hypoxia, and Metabolism
- Wnt/β-catenin signaling in development and cancer
- Cancer Cells and Metastasis
- Receptor Mechanisms and Signaling
- Kruppel-like factors research
- Neuropeptides and Animal Physiology
Experimental Medicine and Biology Institute
2019-2024
Consejo Nacional de Investigaciones Científicas y Técnicas
2019-2024
10.1016/bs.pmbts.2022.06.002
article
EN
Progress in molecular biology and translational science
2022-01-01
Abstract Overcoming luminal breast cancer (BrCa) progression remains a critical challenge for improved overall patient survival. RUNX2 has emerged as protein related to aggressiveness in triple‐negative BrCa, however its role tumors elusive. We have previously shown that active FGFR2 (FGFR2‐CA) contributes increased tumor growth and expression was high hormone‐independent mouse mammary carcinomas. To elucidate the interaction between human we investigated their roles treatment...
10.1002/ijc.35302
article
EN
International Journal of Cancer
2024-12-28
10.1007/s00280-023-04586-9
article
EN
Cancer Chemotherapy and Pharmacology
2023-09-19
Coming Soon ...